Benjamin Cravatt III

Technopedia Center

Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education

Benjamin Cravatt III - Wikipedia

From Wikipedia, the free encyclopedia

(Redirected from Benjamin Cravatt)

Benjamin F. Cravatt III
Born	(1970-04-13) April 13, 1970 (age 54) Houston, Texas, USA
Education	Stanford University B.S. and B.A. (1992) The Scripps Research Institute Ph.D. (1996)
Known for	Proteomics
Scientific career
Fields	Chemical Biology
Institutions	The Scripps Research Institute Vividion Therapeutics ActivX Biosciences Abide Therapeutics
Doctoral advisors	Dale L. Boger Richard Lerner

Benjamin Franklin Cravatt III is a professor in the Department of Chemistry at The Scripps Research Institute in La Jolla, California.^[1] Considered a co-inventor of activity-based proteomics and a substantial contributor to research on the endocannabinoid system, he is a prominent figure in the field of chemical biology. Cravatt was elected to the National Academy of Sciences in 2014,^[1] and the American Academy of Arts and Sciences in 2016.^[2] He is Gilula Chair of Chemical Biology, a Cope Scholar, and a Searle Scholar.

Early life and education

His father was a dentist and his mother a dental hygienist, both of whom instilled in Cravatt an interest in biology as a child.^[1]

Ben Cravatt is left handed.

Cravatt entered Stanford University in 1988, graduating in 1992 with a BS in the Biological Sciences and a BA in History.^[1]^[3] He then received a PhD in Macromolecular and Cellular Structure and Chemistry from The Scripps Research Institute in 1996,^[1] where he worked under the joint supervision of Dale L. Boger and Richard Lerner.

Research

His early contributions to the cannabinoid field include identification and characterization of the endocannabinoid-terminating enzyme fatty acid amide hydrolase (FAAH),^[1] as well as the isolation of the novel soporific compound oleamide from cerebrospinal fluid.^[4]^[5]

Cravatt and colleagues pioneered the activity-based protein profiling (ABPP) chemical proteomic technology, which they used in 2010 to elucidate certain global proteomic features of cysteine proteases.^[1] Cravatt's lab has since combined the ABPP technology with metabolomics.^[1]

Awards and professional service

Among the awards that Cravatt has received are the TR100 Award in 2002, the Eli Lilly Award in Biological Chemistry in 2004, the ASBMB-Merck Award in 2014 and the Sato Memorial Award in 2015.^[1] Cravatt also received an NCI MERIT grant in 2009.^[1] In 2022 he was awarded the Wolf Prize in Chemistry.^[6]

Cravatt is a co-founder of Vividion Therapeutics, Abide Therapeutics and ActivX Biosciences. He formerly served as an Associate Editor for the Journal of the American Chemical Society and Chemical Science.^{[citation needed]}

References

^ ^a ^b ^c ^d ^e ^f ^g ^h ⁱ ^j Viegas, Jennifer (2 February 2016). "Profile of Benjamin Cravatt". Proceedings of the National Academy of Sciences of the United States of America. 113 (5): 1109–11. Bibcode:2016PNAS..113.1109V. doi:10.1073/pnas.1525099113. PMC 4747733. PMID 26811454.
^ "National Academy of Sciences Members and Foreign Associates Elected" (Press release). United States: National Academy of Sciences. 29 April 2014. Archived from the original on 18 August 2015. Retrieved 2016-12-31. Cravatt, Benjamin F.; professor and chair, department of chemical physiology, The Scripps Research Institute, La Jolla, Calif.
^ Bogyo, Matthew; Cravatt, Benjamin F. (February 2007). "Genomics and proteomics: From genes to function: advances in applications of chemical and systems biology". Current Opinion in Chemical Biology (Editorial Overview). 11: 1–3. doi:10.1016/j.cbpa.2006.12.029.
^ Cravatt, B.F.; Giang, D.K.; Mayfield, S.P.; Boger, D.L.; Lerner, R.A. (7 November 1996). "Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides". Nature. 384 (6604): 83–7. Bibcode:1996Natur.384...83C. doi:10.1038/384083a0. PMID 8900284. S2CID 4288981.
^ Cravatt, BF; Prospero-Garcia, O; Siuzdak, G; Gilula, NB; Henriksen, SJ; Boger, DL; Lerner, RA (9 June 1995). "Chemical characterization of a family of brain lipids that induce sleep". Science. 268 (5216): 1506–9. Bibcode:1995Sci...268.1506C. doi:10.1126/science.7770779. PMID 7770779.
^ Wolf Prize in Chemistry 2022

External links

The Scripps Research Institute
The Cravatt Lab at TSRI
Vividion Therapeutics
Abide Therapeutics
ActivX Biosciences
TR35 Young Innovator 2002
Interview with Ben Cravatt on the website of the Royal Society of Chemistry.

Eli Lilly Award in Biological Chemistry

v t e ACS Chemical Biology Lectureship
Alanna Schepartz (2010) Stuart Schreiber (2011) Carolyn Bertozzi (2012) Wilfred A. van der Donk (2013) Peter B. Dervan (2014) Kevan Shokat (2015) Peter G. Schultz (2016) Benjamin Cravatt III (2017) James A. Wells (2018)

Categories:

Hidden categories:

Authority control databases
International	ISNI VIAF WorldCat
National	Germany United States Israel
Academics	ORCID Scopus
Other	IdRef

Early life and education

Research

Awards and professional service

See also

References

External links